Immunotherapy

The Evolving Field of Treatment Modalities

The Evolving Field of Treatment Modalities

Morganna Freeman, DO, FACP
Dr Morganna Freeman considers the future application of treatment modalities and how they might be combined for optimal results.
Learn More
Understanding Immunotherapy

Understanding Immunotherapy

Morganna Freeman, DO, FACP
Dr Morganna Freeman breaks down her methods for explaining immunotherapy to her patients.
Learn More
Is Immunotherapy Appropriate Here?

Is Immunotherapy Appropriate Here?

Morganna Freeman, DO, FACP
Dr Morganna Freeman on the challenge of deciding when to treat a patient with immunotherapy.
Learn More
Changing the Conversation: Immunotherapy and Long-Term Survival

Changing the Conversation: Immunotherapy and Long-Term Survival

Morganna Freeman, DO, FACP
Dr Morganna Freeman discusses some of the ways immunotherapy has changed cancer care, including the expectation for long-term survival and how to treat patients in remission.
Learn More
Choosing Immunotherapy

Choosing Immunotherapy

Morganna Freeman, DO, FACP
Dr Morganna Freeman outlines some of the criteria used in deciding which patients will most benefit from immunotherapy.
Learn More

Back to Top

 

ASSOCIATION

 

MEMBERSHIP

 
Conquer April 2024 Vol 10, No 2
Conquer Logo
Visit the Website
JONS
JONS Logo
Visit the Website

Privacy Notice   |   Terms of Use
© 2009- DBA AONN+ Academy of Oncology Nurse & Patient Navigators®   |   PO Box 563, Cranbury, NJ 08512   |    This email address is being protected from spambots. You need JavaScript enabled to view it.   |    732-992-1532
AONN+ DBA AONN+ is a 501(c)(6) organization under federal tax guidelines. AONN+ Foundation for Learning, Inc. a 501(c)(3) organization under federal tax guidelines.
AONN+ Advantage, LLC, a wholly owned subsidiary of AONN+.